ADI vs ARWR · P/E 61, rev $11.02B vs rev $829.4M
Analog Devices Inc (ADI) versus Arrowhead Pharmaceuticals Inc (ARWR) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. ARWR currently screens at market cap $10.59B.
Not investment advice. Open the ADI and ARWR stock pages for the full models.
Not investment advice.